SCCB
MCID: SML031
MIFTS: 38

Small Cell Carcinoma of the Bladder (SCCB)

Categories: Cancer diseases, Endocrine diseases, Immune diseases, Nephrological diseases, Neuronal diseases, Rare diseases

Aliases & Classifications for Small Cell Carcinoma of the Bladder

MalaCards integrated aliases for Small Cell Carcinoma of the Bladder:

Name: Small Cell Carcinoma of the Bladder 53 59
Small Cell Bladder Cancer 53 59 73
Poorly Differentiated Neuroendocrine Carcinoma of the Bladder 53 59
Small Cell Carcinoma of the Urinary Bladder 53 59
Small Cell Bladder Carcinoma 53 59
Sccb 53 59

Characteristics:

Orphanet epidemiological data:

59
small cell carcinoma of the bladder
Inheritance: Not applicable; Prevalence: <1/1000000 (Europe); Age of onset: Adult; Age of death: elderly;

Classifications:



Summaries for Small Cell Carcinoma of the Bladder

NIH Rare Diseases : 53 The following summary is from Orphanet, a European reference portal for information on rare diseases and orphan drugs.Orpha Number: 284400Disease definitionSmall cell carcinoma of the bladder (SCCB) is a very rare, poorly differentiated neuroendocrine epithelial bladder tumor characterized clinically by hematuria and/or dysuria and a highly aggressive course.EpidemiologySCCB is extremely rare with an annual incidence of less than 1-9/1,000,000. Since 1980, fewer than 1,500 cases have been identified. The demographic profile of SCCB is similar to that of patients with bladder transitional cell carcinoma (TCC). The majority of patients are male, with a mean sex ratio of 5:1, and a range between 1:1 to 16:1. The vast majority of cases were reported in the Caucasian population.Clinical descriptionMost knowledge on SCCB is based on retrospective investigations and on a few prospective studies. Mean age at diagnosis is 67 years (range 32 to 91 years). The clinical features of SCCB are similar to those of bladder TCC and reflect the presence of a tumoral mass. The main symptom is gross hematuria (63 to 88% of cases) with dysuria as the second most common symptom. Urinary obstruction, abdominal pain, urinary tract infection and weigh loss are occasionally present. SCCB often occurs with other types of carcinoma and is frequently found combined with other histological forms of bladder cancer: TCC, adenocarcinoma and squamous cell carcinoma. SCCB is generally believed to have a high metastatic potential. Rare cases of paraneoplastic syndromes such as ectopic ACTH secretion and hypercalcemia have also been reported.EtiologyThe etiology of the disease is unknown but a multipotent stem cell anomaly is thought to be a likely mechanism. A history of smoking is found in 65% to 79% of cases.Diagnostic methodsHistology and immunohistochemistry show a tumor that is indistinguishable from small cell lung cancer (SCLC; see this term). Diagnosis of SCCB relies mainly on histopathological data obtained by cystoscopy and transurethral resection of the bladder tumor. Immunochemistry staining is useful in establishing the diagnosis. Light microscopy reveals packed cells having scant cytoplasm containing few organelles. Tumors are composed of nests of small round malignant cells with pyknotic round to oval nuclei and evenly dispersed ''salt and pepper chromatin''. More than 95% of SCCB cases are diagnosed at muscle invasive stage T2 or later.Differential diagnosisThe differential diagnosis includes direct invasion of the bladder by SCC of the prostate, metastatic SCC from another source, usually the lung, and primary lymphomas of the bladder.Management and treatmentThe staging system used is the TNM-staging of bladder transitional cell carcinoma. Treatment is extrapolated from that of SCLC. However, many patients with SCCB undergo radical resection which is rarely performed in SCLC. Patients with surgically resectable disease should be managed with multimodal therapy associating chemotherapy, surgery and/or radiotherapy. Neoadjuvant chemotherapy using 4 chemotherapy cycles followed by radical cystectomy is the most effective therapeutic sequence. Patients with unresectable disease should be managed with palliative chemotherapy based on neuroendocrine-type regimens comprising a platinum drug (cisplatin in fit patients). Prophylactic cranial irradiation should be considered in stages III/IV bladder SCC.PrognosisThe prognosis of the disease is poor mainly in the case of pure small cell carcinoma.Visit the Orphanet disease page for more resources.

MalaCards based summary : Small Cell Carcinoma of the Bladder, also known as small cell bladder cancer, is related to small cell carcinoma and small cell cancer of the lung. An important gene associated with Small Cell Carcinoma of the Bladder is CHGA (Chromogranin A), and among its related pathways/superpathways is Neuroscience. Affiliated tissues include prostate, lung and ovary, and related phenotypes are abdominal pain and hematuria

Related Diseases for Small Cell Carcinoma of the Bladder

Diseases related to Small Cell Carcinoma of the Bladder via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 264)
# Related Disease Score Top Affiliating Genes
1 small cell carcinoma 30.1 CHGA ENO2 KRT20 KRT7 NKX2-1 SYP
2 small cell cancer of the lung 28.9 CHGA ENO2 KRT20 KRT7 NKX2-1 SYP
3 lung cancer 28.9 CHGA ENO2 KRT20 KRT7 NKX2-1 SYP
4 bladder cancer 10.3
5 spinal meningioma 10.2 CHGA ENO2
6 spinal canal and spinal cord meningioma 10.2 CHGA ENO2
7 diffuse pulmonary fibrosis 10.2 CHGA ENO2
8 duodenal gastrinoma 10.2 CHGA ENO2
9 endocrine organ benign neoplasm 10.2 CHGA SYP
10 primary pigmented nodular adrenocortical disease 10.2 CHGA SYP
11 anterior cranial fossa meningioma 10.2 CHGA SYP
12 pleomorphic xanthoastrocytoma 10.2 CHGA SYP
13 tanycytic ependymoma 10.2 CHGA SYP
14 pancreatoblastoma 10.2 CHGA SYP
15 non-functioning pancreatic endocrine tumor 10.2 CHGA SYP
16 alveolar soft part sarcoma 10.2 ENO2 SYP
17 chondrosarcoma, extraskeletal myxoid 10.2 ENO2 SYP
18 binswanger's disease 10.2 CHGA SYP
19 central nervous system benign neoplasm 10.2 ENO2 SYP
20 bone benign neoplasm 10.2 ENO2 SYP
21 benign glioma 10.2 ENO2 SYP
22 connective tissue benign neoplasm 10.2 ENO2 SYP
23 peripheral nervous system neoplasm 10.2 ENO2 SYP
24 melanotic neuroectodermal tumor 10.2 ENO2 SYP
25 adrenal rest tumor 10.2 ENO2 SYP
26 glomus tumor 10.2 ENO2 SYP
27 optic nerve neoplasm 10.2 ENO2 SYP
28 cerebral ventricle cancer 10.2 ENO2 SYP
29 central nervous system cancer 10.2 ENO2 SYP
30 rhabdoid cancer 10.2 ENO2 SYP
31 medullomyoblastoma 10.2 ENO2 SYP
32 adult medulloblastoma 10.2 ENO2 SYP
33 adrenal carcinoma 10.2 ENO2 SYP
34 angiomyoma 10.2 ENO2 SYP
35 intraocular retinoblastoma 10.2 ENO2 SYP
36 benign ependymoma 10.2 ENO2 SYP
37 optic nerve glioma 10.2 ENO2 SYP
38 pineal parenchymal tumor of intermediate differentiation 10.2 ENO2 SYP
39 pineal gland cancer 10.2 ENO2 SYP
40 hemangioblastoma 10.2 ENO2 SYP
41 cervical clear cell adenocarcinoma 10.2 ENO2 SYP
42 cerebral primitive neuroectodermal tumor 10.2 ENO2 SYP
43 meningeal melanomatosis 10.2 ENO2 SYP
44 desmoplastic small round cell tumor 10.2 ENO2 SYP
45 intracranial primitive neuroectodermal tumor 10.2 CHGA ENO2
46 nervous system benign neoplasm 10.2 ENO2 SYP
47 ganglioneuroblastoma 10.2 ENO2 SYP
48 ependymoma 10.2 ENO2 SYP
49 ureter small cell carcinoma 10.2 CHGA SYP
50 esophageal neuroendocrine tumor 10.2 CHGA SYP

Graphical network of the top 20 diseases related to Small Cell Carcinoma of the Bladder:



Diseases related to Small Cell Carcinoma of the Bladder

Symptoms & Phenotypes for Small Cell Carcinoma of the Bladder

Human phenotypes related to Small Cell Carcinoma of the Bladder:

59 32 (show all 6)
# Description HPO Frequency Orphanet Frequency HPO Source Accession
1 abdominal pain 59 32 occasional (7.5%) Occasional (29-5%) HP:0002027
2 hematuria 59 32 hallmark (90%) Very frequent (99-80%) HP:0000790
3 hypercalcemia 59 32 occasional (7.5%) Occasional (29-5%) HP:0003072
4 recurrent urinary tract infections 59 32 occasional (7.5%) Occasional (29-5%) HP:0000010
5 dysuria 59 32 frequent (33%) Frequent (79-30%) HP:0100518
6 bladder neoplasm 59 32 hallmark (90%) Very frequent (99-80%) HP:0009725

Drugs & Therapeutics for Small Cell Carcinoma of the Bladder

Interventional clinical trials:


# Name Status NCT ID Phase Drugs
1 Prophylactic Cranial Irradiation (PCI) for Small Cell Carcinoma of the Urothelium Active, not recruiting NCT00756639 Phase 2

Search NIH Clinical Center for Small Cell Carcinoma of the Bladder

Genetic Tests for Small Cell Carcinoma of the Bladder

Anatomical Context for Small Cell Carcinoma of the Bladder

MalaCards organs/tissues related to Small Cell Carcinoma of the Bladder:

41
Prostate, Lung, Ovary, Thyroid, Thymus, Pineal, Appendix

Publications for Small Cell Carcinoma of the Bladder

Articles related to Small Cell Carcinoma of the Bladder:

(show top 50) (show all 69)
# Title Authors Year
1
Intravesical recurrence after bladder sparing treatment of small cell carcinoma of the bladder: Characteristics, treatment, and outcome. ( 29580697 )
2018
2
Nomograms to Predict Individual Prognosis of Patients with Primary Small Cell Carcinoma of the Bladder. ( 29675096 )
2018
3
Small cell bladder cancer: should we consider prophylactic cranial irradiation? ( 30521161 )
2018
4
Transcriptomic and Protein Analysis of Small-cell Bladder Cancer (SCBC) Identifies Prognostic Biomarkers and DLL3 as a Relevant Therapeutic Target. ( 30327311 )
2018
5
Radiation Therapy as Definitive Local Treatment in Patients with Limited-Stage Small Cell Carcinoma of the Bladder: Does total dose matter? ( 30112442 )
2018
6
Paraneoplastic stiff person syndrome with small cell carcinoma of the bladder and anti-Ri antibodies. ( 30165320 )
2018
7
The oncological outcomes of small cell carcinoma of the bladder. ( 30526804 )
2018
8
Re: Advanced Small Cell Carcinoma of the Bladder: Clinical Characteristics, Treatment Patterns and Outcomes in 960 Patients and Comparison with Urothelial Carcinoma. ( 28505896 )
2017
9
Orthotopic neobladder in patient with locally advanced small cell carcinoma of the bladder: a case report and review of the literature. ( 28458816 )
2017
10
Treatment Patterns and Survival Outcomes for Patients with Small Cell Carcinoma of the Bladder. ( 28919521 )
2017
11
Clinical analysis of small cell carcinoma of the bladder in Chinese: nine case reports and literature reviews. ( 28125986 )
2017
12
External beam radiation therapy for small cell carcinoma of the bladder. ( 26948133 )
2016
13
Advanced small cell carcinoma of the bladder: clinical characteristics, treatment patterns and outcomes in 960 patients and comparison with urothelial carcinoma. ( 26679712 )
2016
14
Small-Cell Carcinoma of the Bladder: 20-Year Single-Institution Retrospective Review. ( 27991416 )
2016
15
A Case of Primary Small-Cell Carcinoma of the Bladder. ( 27920687 )
2016
16
Small cell carcinoma of the bladder. Report of two cases. ( 27772935 )
2016
17
Long term disease free survival with multimodal therapy in small cell bladder cancer. ( 27737712 )
2016
18
Long-term results of radical cystectomy and role of adjuvant chemotherapy for small cell carcinoma of the bladder. ( 25761779 )
2015
19
Small cell carcinoma of the bladder: Our experience. ( 26331396 )
2015
20
Small cell carcinoma of the bladder. ( 25517085 )
2015
21
A Baffled Mind: A Mysterious Presentation of Small-Cell Carcinoma of the Bladder. ( 25733058 )
2015
22
Long-term outcomes of organ preservation in patients with small cell carcinoma of the bladder. ( 25660255 )
2015
23
POINT: Is Cystectomy Needed for Small-Cell Bladder Cancer? ( 26384800 )
2015
24
COUNTERPOINT: Is Cystectomy Needed for Small-Cell Bladder Cancer? ( 26384801 )
2015
25
Locoregional small cell carcinoma of the bladder: clinical characteristics and treatment patterns. ( 24036236 )
2014
26
Small cell carcinoma of the bladder associated with schistosomiasis: a case report. ( 25803993 )
2014
27
Treatment of Small Cell Carcinoma of the Bladder With Chemotherapy and Radiation after Transurethral Resection of a Bladder Tumor. ( 24517956 )
2014
28
Editorial comment from Dr Koga to local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. ( 23231681 )
2013
29
Editorial comment from Dr Schreiber and Dr Rineer to local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. ( 23231721 )
2013
30
Management of small cell carcinoma of the bladder: Consensus guidelines from the Canadian Association of Genitourinary Medical Oncologists (CAGMO). ( 23671508 )
2013
31
Small cell carcinoma of the bladder: a search of the current literature. ( 23613409 )
2013
32
Characterization and outcomes of small cell carcinoma of the bladder using the surveillance, epidemiology, and end results database. ( 22391430 )
2013
33
Local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. ( 23231456 )
2013
34
Editorial comment from Dr Ismaili to local control rate and prognosis after sequential chemoradiation for small cell carcinoma of the bladder. ( 23231637 )
2013
35
Treatment trends and outcomes of small-cell carcinoma of the bladder. ( 22019246 )
2012
36
Treatment trends and outcomes of small-cell carcinoma of the bladder: in regard to Koay et al. (Int J Radiat Oncol Biol Phys 2011 Oct 20). ( 22385714 )
2012
37
Primary metastatic neuroendocrine small cell bladder cancer: a case report and literature review. ( 22236613 )
2012
38
Small cell bladder cancer: biology and management. ( 23040258 )
2012
39
A Surveillance, Epidemiology, and End Results analysis of small cell carcinoma of the bladder: epidemiology, prognostic variables, and treatment trends. ( 21567387 )
2011
40
Small cell carcinoma of the bladder in transplant recipients: a report of 2 cases. ( 20174486 )
2010
41
Pure Small Cell Carcinoma of the Bladder: A Case Report. ( 29147197 )
2010
42
Long-term survival after sequential chemoradiation for limited disease small cell carcinoma of the bladder. ( 18607595 )
2009
43
Outcome of recurrent and metastatic small cell carcinoma of the bladder. ( 19500382 )
2009
44
Dermatomyositis and small cell carcinoma of the bladder. ( 19826157 )
2009
45
[Case report: a case with small cell carcinoma of the bladder transformed from urothelial carcinoma]. ( 18516922 )
2008
46
Extrapulmonary small cell carcinoma of the bladder. ( 17270661 )
2007
47
Ectopic adrenocorticotropic hormone syndrome in a case of small cell carcinoma of the bladder manifesting as severe muscle weakness. ( 17095061 )
2006
48
Small cell carcinoma of the bladder: a case report and review of the literature. ( 16502047 )
2006
49
Small cell carcinoma of the bladder. ( 16813945 )
2006
50
Protocol consisting of cisplatin, etoposide and irinotecan induced complete pathological remission of primary small cell carcinoma of the bladder. ( 16984565 )
2006

Variations for Small Cell Carcinoma of the Bladder

Cosmic variations for Small Cell Carcinoma of the Bladder:

9 (show top 50) (show all 22547)
# Cosmic Mut ID Gene Symbol COSMIC Disease Classification
(Primary site, Site subtype, Primary histology, Histology subtype)
Mutation CDS Mutation AA GRCh38 Location Conf
1 COSM6933774 ZRSR2 urinary tract,bladder,carcinoma,transitional cell carcinoma c.965G>A p.R322K 23:15822758-15822758 27
2 COSM6933517 ZRSR2 urinary tract,bladder,carcinoma,transitional cell carcinoma c.946G>C p.E316Q 23:15822739-15822739 27
3 COSM6975086 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.8390G>T p.R2797I 16:72794292-72794292 27
4 COSM6949043 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.2249A>G p.H750R 16:72957897-72957897 27
5 COSM1379719 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.4595A>G p.N1532S 16:72798087-72798087 27
6 COSM6929527 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.808G>A p.D270N 16:72959338-72959338 27
7 COSM6954831 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.1907C>T p.S636L 16:72958239-72958239 27
8 COSM6976091 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.4937C>T p.S1646F 16:72797745-72797745 27
9 COSM6965513 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.8711A>G p.K2904R 16:72793971-72793971 27
10 COSM6967093 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.883C>T p.R295C 16:72959263-72959263 27
11 COSM6971431 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.11065A>T p.K3689* 16:72787211-72787211 27
12 COSM4499983 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.554C>T p.S185L 16:72959592-72959592 27
13 COSM6503148 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.2458C>T p.R820C 16:72957688-72957688 27
14 COSM6933052 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.625G>A p.E209K 16:72959521-72959521 27
15 COSM6975088 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.5416G>C p.E1806Q 16:72797266-72797266 27
16 COSM6928012 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.7799C>G p.S2600* 16:72794883-72794883 27
17 COSM6929526 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.8376G>A p.M2792I 16:72794306-72794306 27
18 COSM6975375 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.9127A>G p.I3043V 16:72793555-72793555 27
19 COSM6954830 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.2434G>C p.E812Q 16:72957712-72957712 27
20 COSM6975087 ZFHX3 urinary tract,bladder,carcinoma,transitional cell carcinoma c.7576C>T p.Q2526* 16:72795106-72795106 27
21 COSM6931485 YES1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.460C>G p.Q154E 18:747930-747930 27
22 COSM6920698 YES1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.595C>T p.R199C 18:745837-745837 27
23 COSM6981599 YES1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.1342C>T p.R448W 18:732915-732915 27
24 COSM6926471 YAP1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.182C>G p.S61W 11:102111030-102111030 27
25 COSM3054551 XPO1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.948G>C p.Q316H 2:61495554-61495554 27
26 COSM6919160 XPO1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.649C>G p.Q217E 2:61498783-61498783 27
27 COSM6925335 XPO1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.1531G>A p.E511K 2:61492602-61492602 27
28 COSM6944646 XPO1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.1174C>G p.P392A 2:61493965-61493965 27
29 COSM6917743 XPO1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.2359G>A p.D787N 2:61485917-61485917 27
30 COSM6906541 XIAP urinary tract,bladder,carcinoma,transitional cell carcinoma c.739G>A p.D247N 23:123886401-123886401 27
31 COSM6928215 WT1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.860G>A p.R287K 11:32399982-32399982 27
32 COSM6933306 WT1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.213C>A p.F71L 11:32434929-32434929 27
33 COSM6191549 WT1 urinary tract,bladder,carcinoma,adenocarcinoma c.1282T>C p.S428P 11:32389126-32389126 27
34 COSM2114555 WT1 urinary tract,bladder,carcinoma,adenocarcinoma c.847G>A p.G283R 11:32399995-32399995 27
35 COSM6930292 VTCN1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.55C>G p.L19V 1:117170149-117170149 27
36 COSM727511 VHL urinary tract,bladder,carcinoma,transitional cell carcinoma c.235C>G p.R79G 3:10142082-10142082 27
37 COSM296967 VEGFA urinary tract,bladder,carcinoma,transitional cell carcinoma c.1175G>A p.R392H 6:43782045-43782045 27
38 COSM3352159 VEGFA urinary tract,bladder,carcinoma,transitional cell carcinoma c.543G>A p.M181I 6:43771249-43771249 27
39 COSM146287 U2AF1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.101C>A p.S34Y 21:43104346-43104346 27
40 COSM6908635 U2AF1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.509A>G p.N170S 21:43094537-43094537 27
41 COSM6927446 U2AF1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.695G>C p.R232T 21:43093130-43093130 27
42 COSM6967105 U2AF1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.676C>T p.R226C 21:43093149-43093149 27
43 COSM6907163 U2AF1 urinary tract,bladder,carcinoma,transitional cell carcinoma c.217G>C p.E73Q 21:43095726-43095726 27
44 COSM5611118 TSHR urinary tract,bladder,carcinoma,transitional cell carcinoma c.2152G>A p.D718N 14:81144210-81144210 27
45 COSM6948162 TSHR urinary tract,bladder,carcinoma,transitional cell carcinoma c.1477G>C p.G493R 14:81143535-81143535 27
46 COSM6984162 TSHR urinary tract,bladder,carcinoma,transitional cell carcinoma c.837C>G p.Y279* 14:81139823-81139823 27
47 COSM6977822 TSHR urinary tract,bladder,carcinoma,transitional cell carcinoma c.2024C>T p.P675L 14:81144082-81144082 27
48 COSM1230676 TSHR urinary tract,bladder,carcinoma,transitional cell carcinoma c.2101C>T p.R701C 14:81144159-81144159 27
49 COSM6928753 TSC2 urinary tract,bladder,carcinoma,transitional cell carcinoma c.1223T>G p.F408C 16:2061974-2061974 27
50 COSM6282498 TSC2 urinary tract,bladder,carcinoma,transitional cell carcinoma c.2713C>T p.R905W 16:2076141-2076141 27

Expression for Small Cell Carcinoma of the Bladder

Search GEO for disease gene expression data for Small Cell Carcinoma of the Bladder.

Pathways for Small Cell Carcinoma of the Bladder

Pathways related to Small Cell Carcinoma of the Bladder according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 11.33 ENO2 NKX2-1 SYP

GO Terms for Small Cell Carcinoma of the Bladder

Sources for Small Cell Carcinoma of the Bladder

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 SNOMED-CT via Orphanet
71 TGDB
72 Tocris
73 UMLS
74 UMLS via Orphanet
Content
Loading form....